Targeting bone morphogenetic protein receptor 2 sensitizes lung cancer cells to TRAIL by increasing cytosolic Smac/DIABLO and the downregulation of X-linked inhibitor of apoptosis protein

Nemoyer, R., Mondal, A., Vora, M., Langenfeld, E., Glover, D., Scott, M., … Langenfeld, J. (2019). Targeting bone morphogenetic protein receptor 2 sensitizes lung cancer cells to TRAIL by increasing cytosolic Smac/DIABLO and the downregulation of X-linked inhibitor of apoptosis protein. Cell Communication and Signaling, 17(1). https://doi.org/10.1186/s12964-019-0469-5